|
|
COLLABORATORS
Neogenix Oncology® is committed to the discovery, development and commercialization of novel cancer therapeutics and diagnostics. Neogenix has active collaborations with a growing number of organizations, among them: Clinical and Research Johns Hopkins Hospital Duke University Medical Center North Shore University Hospital Conemaugh Cancer Care Center San Raffaele Pisana Commercial Product Development Cytovance Biologics, Inc Bioreliance, Inc. Selexis, S.A. Catalent Pharma Solutions To inquire about potential partnerships or collaboration, please contact: info@neogenix.com |
![]() “Great partnerships begin with great partners, and a common passion for doing the right thing for patients.” Philip M. Arlen, MD Chief Executive Officer |

